Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2023, 11(3), 60-62
DOI: 10.12691/AJMCR-11-3-5
Case Report

Ketamine Bladder: A Cause of Obstructive Uropathy in a Young Patient

Rim Aly1, and Rabab Elhassan1

1Clinical Radiology, Countess of Chester Hospital, Chester, United Kingdom

Pub. Date: March 17, 2023
Full Text PDF

Cite this paper

Rim Aly and Rabab Elhassan. Ketamine Bladder: A Cause of Obstructive Uropathy in a Young Patient. American Journal of Medical Case Reports. 2023; 11(3):60-62. doi: 10.12691/AJMCR-11-3-5

Abstract

Ketamine-associated cystitis is growing in prevalence as the availability and use of illicit drugs increases. Delayed diagnosis and management can lead to poor patient outcomes including irreversible renal impairment. Early diagnosis, ketamine cessation and management of complications is therefore crucial. There are only a few case reports in the literature describing this condition. We report an additional case of a young patient with ketamine-associated ulcerative cystitis causing upstream obstructive uropathy.

Keywords

ketamine, cystitis, uropathy

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM: The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 2012, 110: 1762-1766.
 
[2]  Ho CC, Pezhman H, Praveen S, et al.: Ketamine-associated ulcerative cystitis: a case report and literature review. Malays J Med Sci. 2010, 17: 61-5.
 
[3]  Li CC, Wu ST, Cha TL, Sun GH, Yu DS, Meng E: A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan. Sci Rep. 2019, 9: 7240.
 
[4]  Hong YL, Yee CH, Tam YH, Wong JH, Lai PT, Ng CF: Management of complications of ketamine abuse: 10 years' experience in Hong Kong . Hong Kong Med J.. 2018, 24: 175-181.
 
[5]  Zeng J, Lai H, Zheng D, et al.: Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. J Int Med Res. 2017, 45: 792-797.
 
[6]  Anderson DJ, Zhou J, Cao D, et al.: Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug. Health Psychol Res. 2022, 10: 38247.